IRIS UniCatt

Marino, Mariapaola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.404
AS - Asia 3.026
EU - Europa 2.305
SA - Sud America 609
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 86
OC - Oceania 15
Totale 10.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.226
SG - Singapore 1.425
CN - Cina 656
SE - Svezia 552
BR - Brasile 502
IT - Italia 431
DE - Germania 337
VN - Vietnam 281
FR - Francia 261
GB - Regno Unito 129
IE - Irlanda 129
IN - India 120
BD - Bangladesh 109
CA - Canada 93
JP - Giappone 90
ID - Indonesia 84
UA - Ucraina 78
FI - Finlandia 76
RU - Federazione Russa 72
PL - Polonia 64
HK - Hong Kong 61
MX - Messico 54
AR - Argentina 36
ES - Italia 32
TR - Turchia 31
IQ - Iraq 30
ZA - Sudafrica 30
BE - Belgio 29
NL - Olanda 29
KR - Corea 27
AT - Austria 18
CO - Colombia 16
MA - Marocco 16
EC - Ecuador 15
CH - Svizzera 13
UZ - Uzbekistan 13
CI - Costa d'Avorio 12
VE - Venezuela 12
PK - Pakistan 11
CL - Cile 10
IR - Iran 10
JO - Giordania 10
SA - Arabia Saudita 10
AU - Australia 9
CZ - Repubblica Ceca 9
KE - Kenya 8
CR - Costa Rica 7
BY - Bielorussia 6
HN - Honduras 6
LB - Libano 6
LT - Lituania 6
MY - Malesia 6
NZ - Nuova Zelanda 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
KZ - Kazakistan 5
OM - Oman 5
TN - Tunisia 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
NO - Norvegia 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PE - Perù 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
GA - Gabon 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
TH - Thailandia 2
TM - Turkmenistan 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
LU - Lussemburgo 1
Totale 10.436
Salva come PNG Salva come JPEG
Città #
Singapore 845
Ashburn 560
Chandler 532
San Jose 375
New York 165
Beijing 144
Los Angeles 140
Dublin 129
Rome 105
Ho Chi Minh City 97
Dallas 89
San Mateo 89
Tokyo 87
The Dalles 84
Council Bluffs 79
Hefei 77
Jakarta 76
Lauterbourg 72
Hanoi 65
Milan 59
North Bergen 59
Frankfurt am Main 58
Boston 57
Chicago 56
Hong Kong 56
Marseille 52
São Paulo 51
Cattolica 49
Munich 49
Wilmington 49
Santa Clara 48
Princeton 46
Ann Arbor 45
Cambridge 45
Moscow 44
Jacksonville 43
Helsinki 42
Orem 41
Houston 39
Boardman 35
Bremen 35
Redwood City 33
Warsaw 29
Montreal 27
Paris 27
Buffalo 26
Dearborn 26
Woodbridge 26
Denver 25
Nanjing 25
Atlanta 23
Chennai 23
Hyderabad 23
Seoul 23
Toronto 23
Brussels 22
Kent 22
Seattle 22
Brooklyn 20
Da Nang 19
Johannesburg 19
London 19
Nuremberg 19
Rio de Janeiro 19
Stockholm 19
San Francisco 18
Bologna 17
Kraków 17
Amsterdam 15
Baghdad 15
Falls Church 15
Norwalk 15
Phoenix 15
Lappeenranta 13
Manchester 13
Mexico City 13
Querétaro 13
Abidjan 12
Charlotte 12
Des Moines 12
Dhaka 12
Washington 12
Falkenstein 11
Naples 11
Tashkent 11
Turku 11
Brasília 10
City of London 10
Fairfield 10
Lawrence 10
Poplar 10
Amman 9
Belo Horizonte 9
Düsseldorf 9
Edinburgh 9
Haiphong 9
Hangzhou 9
Nanchang 9
Quito 9
Roubaix 9
Totale 5.841
Salva come PNG Salva come JPEG
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 270
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 243
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 230
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 205
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 204
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 202
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 194
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 187
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 180
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 172
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 169
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 167
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 167
Myasthenia gravis with antibodies to MuSK: an update 165
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 165
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 164
Immunological role of IgG subclasses 161
Skeletal muscle cells: from local inflammatory response to active immunity 159
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 159
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 155
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 155
Fluidi ed elettroliti. Equilibrio acido-base 154
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 151
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 150
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 149
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 147
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 144
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 143
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 139
Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro 138
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 137
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 137
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 136
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 134
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 132
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 131
Immunological role of IgG subclasses 129
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 128
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 128
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 127
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 127
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 127
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 124
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 123
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 123
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 123
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 123
The Laboratory Role in anti-TNF Biological Therapy Era 122
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 122
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 120
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 118
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 117
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 108
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 106
The dark side of current analytic methods for Bence Jones Proteinuria 105
Cryoglobulins: putative effectors of adaptive immune response 104
IL-6, monocyte infiltration and parenchymal cells 104
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 103
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 102
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 102
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 101
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 100
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 99
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 97
Type 2 cytokines and scleroderma interstitial lung disease 92
Free light chains and autoimmunity 90
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 89
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 88
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 87
Calprotectin: two sides of the same coin 86
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 85
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 85
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 83
Immune-inflammatory response changes in patients with major depressive disorder 83
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 79
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 79
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 72
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 71
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 67
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 65
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 62
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 54
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 8
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot Study 5
Autoimmune and Inflammatory Diseases: Identifying New Advances in Immunological Insights 4
Totale 10.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022576 0 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/20251.866 75 68 131 66 143 85 51 110 308 157 386 286
2025/20264.755 579 121 324 682 901 227 823 260 250 298 140 150
2026/2027245 172 73 0 0 0 0 0 0 0 0 0 0
Totale 10.641